Department of Nephrology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, China ...

全球股市正迎来“黑色星期一”。 4月7日，A股清明节假期后开盘。早盘，三大股指全线低开，沪指低开4.46%，深指低开5.96% ...

ALX2004 is a potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors that was created from ALX Oncology’s proprietary linker-payload ...

1Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. 2Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Sotiria ...

For example, the estimated glomerular filtration rate (EGFR) indicates possible kidney disease when it drops below a 60 milliliter (ml) per minute rate. Other tests include the blood urea nitrogen ...

Lazertinib is an oral, highly selective, third-generation EGFR tyrosine kinase inhibitor that can penetrate the brain, and amivantamab is a bispecific antibody targeting EGFR and mesenchymal ...

然而，众多研究中，一项由中山大学附属肿瘤医院的方文峰教授主导的研究引发了广泛关注，聚焦于大剂量阿美替尼在少见EGFR突变非小细胞肺癌（NSCLC）中的应用，尤其是EGFR20外显子插入突变（20ins）患者的疗效与安全性。 研究背景 在过去的研究中，少见EGFR ...

2025年3月26日，强生公司（Johnson & Johnson）公布了EGFR/MET双抗埃万妥单抗注射液（Amivantamab）联合拉泽替尼（Lazertinib）一线治疗 ...